Valiant Laboratories: Trading Window Closed from April 1, 2026 for Q4FY26 Results
Valiant Laboratories Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026, as per SEBI regulations.
The closure of the trading window is a standard compliance requirement and does not directly impact the company's operations or financial performance. It is a procedural step that affects insider trading activities around the announcement of financial results.
The announcement is a routine regulatory disclosure regarding the closure of the trading window, which is standard practice before financial results are announced. It does not contain any new financial information or operational updates that would directly impact the company's valuation or performance.
Valiant Laboratories Limited has announced the closure of its trading window for all directors, promoters, promoter group, designated persons, their immediate relatives, and connected persons. This closure will be effective from April 01, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter and year ended March 31, 2026.
The decision is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for Prevention of Insider Trading. The company has also uploaded this intimation on its official website, www.valiantlabs.in.
What to do with a filing like this
Valiant Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Valiant Laboratories Limited. Read the original for the full detail.